Hypertension Surveillance in Rural Regions of Iran
-
Mohammad Hossein PANAHI
,
Ali Reza MAHDAVI HEZAVEH
,
Tahereh SAMAVAT
,
Alieh HODJATZADEH
,
Elham YOUSEFI
Abstract
Abstracts Abstracts Abstracts Abstracts
1. Rapsomaniki E, Timmis A, George J, et al (2014). Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1• 25 million peo-ple. Lancet, 383(9932):1899-911.
2. Angeli F, Reboldi G, Verdecchia P (2007). Hypertension, inflammation and atrial fi-brillation. J Hypertens, 32(3):480-3.
3. Wolf-Maier K, Cooper RS, Banegas JR, G, et al (2003). Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA, 289(18):2363-9.
4. Chen J (2010). Epidemiology of hyperten-sion and chronic kidney disease in China. Curr Opin Nephrol Hypertens, 19(3):278-82.
5. Kearney PM, Whelton M, Reynolds K, et al (2005). Global burden of hypertension: analysis of worldwide data. Lancet, 365(9455):217-23.
6. Papathanasiou G, Zerva E, Zacharis I, et al (2015). Association of high blood pres-sure with body mass index, smoking and physical activity in healthy young adults. Open Cardiovasc Med J, 9:5-17.
7. Chockalingam A (2007). Impact of world hypertension day. Can J Cardiol, 23(7):517-9.
8. Maftoon F, Farzadi F, AeenParast A, et al (2016). Evaluation of National Program on Prevention and Control of Hyperten-sion: The Study Protocol. Adv Biores, 7(3): 15-20.
9. Antonakoudis G, Poulimenos I, Kifnidis K, et al (2007). Blood pressure control and cardiovascular risk reduction. Hippokratia, 11(3):114-119.
10. Health NIo, National Heart L, Institute B (2003). Your guide to lowering blood pressure. National Institutes of Health Publica-tion, (03-5232):1-20.
2. Angeli F, Reboldi G, Verdecchia P (2007). Hypertension, inflammation and atrial fi-brillation. J Hypertens, 32(3):480-3.
3. Wolf-Maier K, Cooper RS, Banegas JR, G, et al (2003). Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA, 289(18):2363-9.
4. Chen J (2010). Epidemiology of hyperten-sion and chronic kidney disease in China. Curr Opin Nephrol Hypertens, 19(3):278-82.
5. Kearney PM, Whelton M, Reynolds K, et al (2005). Global burden of hypertension: analysis of worldwide data. Lancet, 365(9455):217-23.
6. Papathanasiou G, Zerva E, Zacharis I, et al (2015). Association of high blood pres-sure with body mass index, smoking and physical activity in healthy young adults. Open Cardiovasc Med J, 9:5-17.
7. Chockalingam A (2007). Impact of world hypertension day. Can J Cardiol, 23(7):517-9.
8. Maftoon F, Farzadi F, AeenParast A, et al (2016). Evaluation of National Program on Prevention and Control of Hyperten-sion: The Study Protocol. Adv Biores, 7(3): 15-20.
9. Antonakoudis G, Poulimenos I, Kifnidis K, et al (2007). Blood pressure control and cardiovascular risk reduction. Hippokratia, 11(3):114-119.
10. Health NIo, National Heart L, Institute B (2003). Your guide to lowering blood pressure. National Institutes of Health Publica-tion, (03-5232):1-20.
| Files | ||
| Issue | Vol 48 No 12 (2019) | |
| Section | Letter to the Editor | |
| DOI | https://doi.org/10.18502/ijph.v48i12.3571 | |
| Keywords | ||
| Keywords Keywords Keywords | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
PANAHI MH, MAHDAVI HEZAVEH AR, SAMAVAT T, HODJATZADEH A, YOUSEFI E. Hypertension Surveillance in Rural Regions of Iran. Iran J Public Health. 2019;48(12):2313-2314.
